- Polypill Strategy in Secondary Cardiovascular Prevention2022 | First Faculty of Medicine
- Blockade of the renin-angiotensin-aldosteron system (RAAS) in secondary cardiovascular prevention2009 | First Faculty of Medicine
- What does current dyslipidemia treatment look like in clinical practice?2016 | Faculty of Medicine in Pilsen
- Is it atorvastatin use fit for consumption in the morning?2016 | Faculty of Medicine in Pilsen
- Ezetimibe/atorvastatin - new combination of lipid-modifying drugs2017 | Faculty of Medicine in Pilsen
- Anti-obesity drug with exceptional benefit for preventive cardiology: current results of the SELECT trial2023 | First Faculty of Medicine
- Intake of Carp Meat From Two Aquaculture Production Systems Aimed at Secondary Prevention of Ischemic Heart Disease a Follow-up Study2017 | Central Library of Charles University
- Evolocumab, proproteine convertase subtilisin/kexin type 9 inhibitor for intensive treatment of dyslipidemia2016 | Faculty of Medicine in Pilsen
- The polypill in cardiovascular prevention: evidence, limitations and perspective - position paper of the European Society of Hypertension2017 | First Faculty of Medicine
- Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: Results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry2019 | First Faculty of Medicine
- Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease2017 | Third Faculty of Medicine